|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 23, No 16 (June 1), 2005: pp. 3802-3810 © 2005 American Society of Clinical Oncology. DOI: 10.1200/JCO.2005.06.742 Analysis of Treatment Practices for Elderly Cancer Patients in Ontario, CanadaFrom the Princess Margaret Hospital; University of Toronto; Ontario Cancer Registry, Toronto; and Northwestern Ontario Regional Cancer Centre, Thunder Bay, Ontario, Canada Address reprint requests to Lillian L. Siu, MD, FRCPC, Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, 610 University Ave, Ste 5-210, Toronto, Ontario, M5G 2M9, Canada; e-mail: lillian.siu{at}uhn.on.ca PURPOSE: Older patients are underrepresented in many areas of cancer services utilization and in clinical trial enrollment. This study evaluates whether age, when adjusted for sex, comorbidity, stage, tumor site, geography, and time period, is predictive of cancer treatment practice.
METHODS: First, we used the Ontario Cancer Registry (OCR) to examine for any apparent differences in treatment practices between elderly ( RESULTS: OCR data demonstrated that, in some settings, such as colorectal cancer, the proportions of elderly cancer patients who were referred to cancer centers and who received any cancer treatment were lower than their younger counterparts. The chart review data showed that increasing age was a significant negative predictor for receiving any cancer treatment (P < .001, multivariate analysis) and for having a clinical trial discussion with the treating specialist (P < .001, multivariate analysis). CONCLUSION: Independent of other factors, older age is consistently a cause of disparity in cancer treatment practice and in clinical trial discussion with patients. By increasing the accrual rate of elderly cancer patients in clinical trials, a better understanding of appropriate therapies for this patient population can be obtained and may, thereby, impact on their cancer-related morbidity and mortality. Authors' disclosures of potential conflicts of interest are found at the end of this article. This article has been cited by other articles:
|
||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|